One of the more important things to keep in mind with regard to successful stock picking is that investors are almost always looking for value in order to make long-term wealth. The stock which may be undervalued by the market may be available at a discount and hence, once those stocks breakout then investors might end up making handsome profits. This article is going to look into the medical and wellness sector for stocks which may be undervalued and that investors could consider tracking. Here is a quick look at six of those stocks.
Immunoprecise Antibodies Ltd (NASDAQ:IPA) – The first one to look into from among potentially undervalued medical stocks is that of IPA. This morning the company made a key announcement about its Belgian subsidiary company Biostrand, a full-service multi-omics analytical platform provider. It was announced this morning that Biostrand had managed to get a grant of as much as 460,000 Euros from Flanders Innovation & Entrepreneurship.
It is the research fund that belongs to the local Flemish government in Belgium. It goes without saying that the award was a significant development for Biostrand and one that is expected to work as a major boost for the IPA subsidiary in the near tear. It may be a good idea to keep it on your watch lists over the course of the coming days.
Kaival Brands (NASDAQ:KAVL) is best known for being the worldwide distributor of products made by BidiVapor LLC. While there has been no news about the company today so far, it may be a good idea to look into the announcement from Kaival Brands back on May 4.
The company announced that its Chief Operating Officer, Eric Mosser, and its Chief Executive Officer, Niraj Patel were going to participate in a presentation at the Sidoti May Micro Cap Virtual Conference. The conference is going to be held from May 11 to May 12. Investors could keep an eye on the events in the coming days.
XORTX Therapeutics Inc (NASDAQ: XRTX) – Clinical stage biopharmaceutical firm XORTX Therapeutics is one of the medical stocks that could be considered undervalued at this point in time. The company had actually been in the news cycle back on Thursday last week that the United States Food and Drug Administration had provided it with the notification with regards to the approval and clearance of its Investigative New Drug application.
In addition to that notification, XORTX has also been provided with a letter indicating that ‘study may proceed’ with regards to the product XRX-OXY-101. It was a significant development for XORTX considering the fact that the application also supports its XRx-008 initiative for the treatment of progressive kidney disease.
CeCors, Inc. (OTCMKTS:CEOS) –. The company is involved in developing and commercializing nootropic, entheogenic and adaptogenic formulations and ingredients that are based on mycology.
The company is primarily involved in the functional mushrooms space and is involved in the manufacturing of all kinds, starting from the functional ones to the psychedelic ones. The company has also come up with its own optimal wellness strategy and it may be an interesting company to follow in an industry that is still at a fairly nascent stage.
Therma Bright Inc (OTCMKTS:TBRIF) (THRM.V) – The next one to enter the list is the medical device technology company Therma Bright Inc, which is currently best known for having developed the AcuVid Covid-19 Rapid Antigen Saliva Test. Yesterday the company announced that the initial order of the updated version of its product Venowave had been shipped.
The product was shipped to DME Authority LLC, which is the distributor for Therma Bright in the United States. The product had been shipped to the distributor by the company’s Chinese manufacturing contractor. The order in question was for 2500 units and each unit is made up of 2 Venowave devices. 500 of those units had been shipped away by air and the rest by way of the sea. It may now be a good time for investors to keep an eye on further developments with regard to Therma Bright over the coming days.
Halberd Corporation (OTCMKTS:HALB) – Last but certainly not least, it is the Halberd Corporation stock that could be added to this list. Back on April 29, it emerged that at a Tedx Talk delivered by Dr. W Gregg Surrus, the company’s extracorporeal treatment meant for the treatment of neurodegenerative disease was mentioned.
mentioned at a TedX Talk is almost always a major development for any company and hence, it was the same for Halberd Corporation. It now remains to be seen if the stock can actually gain any traction among investors in the coming days.
